GO:0003171 atrioventricular valve development: Morphogenesis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003171 atrioventricular valve development describes the progression of the atrioventricular (AV) valve over time, from its formation to the mature structure.
• AV valve development requires coordinated endocardial cushion formation, epithelial-to-mesenchymal transition, valve leaflet remodeling, and formation of the tension apparatus including chordae tendineae and papillary muscles.
• The epicardium contributes cells and paracrine signals that are essential for normal AV valve development and for preventing myxomatous valve disease.
• Biomechanical cues from blood flow and cardiac contraction direct valvulogenesis and are required for proper AV valve morphogenesis.
• Disruption of AV valve development causes congenital heart defects such as atrioventricular septal defects and later valve regurgitation.
• Research on GO:0003171 uses animal models, lineage tracing, gene knockout, and CRISPR-based editing to dissect gene function in valve formation.
Description
Atrioventricular valve development (GO:0003171) is the biological process by which the atrioventricular valves, the mitral and tricuspid valves, progress from their initial formation to a mature, functional structure. These valves separate the atrial and ventricular chambers and are essential for unidirectional blood flow through the heart. The process encompasses endocardial cushion formation, cellular differentiation, leaflet remodeling, and development of the tension apparatus that anchors the valve leaflets. Understanding GO:0003171 is critical because defects in AV valve development are a major cause of congenital heart disease and can lead to valve regurgitation requiring surgical or transcatheter intervention. The study of atrioventricular valve development integrates developmental biology, genetics, biomechanics, and clinical cardiology. Key cellular events include endothelial-to-mesenchymal transition in the endocardial cushions, proliferation and apoptosis during remodeling, and extracellular matrix reorganization. The epicardium has emerged as an important source of cells and signals that influence AV valve maturation and homeostasis. Biomechanical forces generated by blood flow and cardiac contraction provide instructive cues that shape valve leaflets and the tension apparatus. For researchers, GO:0003171 provides a defined framework to annotate genes and pathways involved in AV valve formation. Mutations in genes regulating cushion formation, EMT, and matrix remodeling can cause AV valve malformations and are studied using knockout, knock-in, and overexpression models. This article reviews the definition, mechanisms, key genes, disease links, and research methods for GO:0003171, with a focus on how CRISPR-based cell models can accelerate discovery.
atrioventricular valve development At A Glance
| GO ID | GO:0003171 |
|---|---|
| GO term | atrioventricular valve development |
| Ontology | biological_process |
| Synonym | AV valve development |
| Definition | The progression of the atrioventricular valve over time, from its formation to the mature structure. |
| Major function | Formation and maturation of the mitral and tricuspid valves, including leaflets and tension apparatus. |
| Related anatomy | Endocardial cushions, valve leaflets, chordae tendineae, papillary muscles. |
| Key processes | Endothelial-to-mesenchymal transition, remodeling, extracellular matrix organization, biomechanical signaling. |
| Disease relevance | Atrioventricular septal defects, valve regurgitation, myxomatous valve disease. |
What Is GO:0003171?
GO:0003171 atrioventricular valve development is defined as the progression of the atrioventricular valve over time, from its formation to the mature structure. In practical terms, it covers all cellular and molecular events that transform the initial endocardial cushion into mature AV valve leaflets, chordae tendineae, and papillary muscles, ensuring proper valve function.
Why Is atrioventricular valve development Important in Cell Biology?
Atrioventricular valve development is essential for normal cardiac function because the AV valves ensure unidirectional blood flow between the atria and ventricles. Defects in this process cause congenital heart malformations, including atrioventricular septal defects, and can lead to valve regurgitation that requires surgical or transcatheter correction. Understanding the molecular and cellular mechanisms of GO:0003171 is therefore critical for diagnosing, preventing, and treating congenital and acquired valve diseases.
• AV valve development is required for unidirectional blood flow and normal cardiac function.
• Disruption of AV valve development causes congenital heart defects such as atrioventricular septal defects.
• Defective AV valve development can lead to valve regurgitation later in life.
• The epicardium contributes to AV valve development and its dysfunction is linked to myxomatous valve disease.
• Biomechanical cues are essential for proper valvulogenesis and AV valve maturation.
• Genes controlling endothelial-to-mesenchymal transition are central to AV valve formation.
• Animal models of AV valve development provide insight into human congenital heart disease.
• Understanding AV valve development informs tissue engineering and regenerative strategies for valve repair.
• AV valve development research helps predict and manage complications after transcatheter aortic valve replacement.
• CRISPR-based models enable functional dissection of genes involved in AV valve development.
What Happens During atrioventricular valve development?
Endocardial cushion formation
In simple terms: The heart first builds soft cushions that will become the valve leaflets.
AV valve development begins with the formation of endocardial cushions in the atrioventricular canal. Endocardial cells undergo endothelial-to-mesenchymal transition and invade the extracellular matrix of the cushions, forming the primordia of the valve leaflets. These cushions are populated by mesenchymal cells derived from endocardium and epicardium, and their proper formation is a prerequisite for subsequent valve morphogenesis.
Epithelial-to-mesenchymal transition and cell migration
In simple terms: Cells change identity and move into the cushions to build the valve.
Endothelial-to-mesenchymal transition (EndoMT) is a key cellular process in AV valve development. Endocardial cells lose endothelial markers, gain mesenchymal markers, and migrate into the cushion matrix. Signaling pathways such as TGF-beta and BMP regulate this transition, and disruption of EndoMT leads to defective valve formation. Epicardial-derived cells also migrate into the AV valves and contribute to valve interstitial cell populations.
Valve leaflet remodeling and stratification
In simple terms: The cushions are sculpted into thin, strong leaflets.
After cushion formation, the primitive valve structures undergo remodeling to form stratified leaflets with distinct layers: fibrosa, spongiosa, and atrialis. This involves coordinated proliferation, apoptosis, and extracellular matrix reorganization. The tension apparatus, including chordae tendineae and papillary muscles, develops in parallel to anchor the leaflets and ensure proper coaptation. In the human heart, the tension apparatus develops through a series of morphological stages that can be observed during fetal development.
Biomechanical signaling
In simple terms: Blood flow and heartbeats provide physical cues that shape the valves.
Biomechanical cues generated by blood flow and cardiac contraction are essential for valvulogenesis. Shear stress and strain influence endothelial cell signaling, extracellular matrix remodeling, and valve leaflet maturation. These mechanical forces are transduced into biochemical signals that regulate gene expression and cell behavior during AV valve development.
Maturation and postnatal adaptation
In simple terms: The valves continue to mature after birth to handle adult blood flow.
AV valve development continues postnatally with growth and adaptation of leaflets and tension apparatus to increasing hemodynamic loads. The mature valve structure is maintained by valve interstitial cells and endothelial cells, and disruptions in this maturation process can lead to valve disease later in life. Epicardial contributions to valve homeostasis are important for preventing myxomatous degeneration.
Key Genes Involved in GO:0003171 atrioventricular valve development
The following genes and proteins are experimentally implicated in atrioventricular valve development and related valvulogenesis pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TGFB2 | Regulates endothelial-to-mesenchymal transition in endocardial cushions | Knockout models show defective AV valve formation |
| BMP2 | Signaling in AV cushion formation and valve remodeling | Conditional knockout alters valve morphogenesis |
| NOTCH1 | Controls EndoMT and valve leaflet stratification | Mutations linked to valve disease |
| NFATC1 | Regulates valve remodeling and leaflet maturation | Knockout causes valve defects |
| VEGFA | Promotes endocardial cushion growth and angiogenesis | Overexpression models affect valve development |
| WT1 | Epicardial marker contributing to valve interstitial cells | Lineage tracing shows epicardial contribution |
| TBX18 | Epicardial signaling in AV valve development | Knockout affects valve maturation |
| GATA4 | Transcription factor in endocardial cushion formation | Mutations associated with AV septal defects |
| NKX2-5 | Regulates cardiac development including AV valve formation | Knockout models show valve abnormalities |
| SOX9 | Required for valve progenitor differentiation | Conditional knockout impairs valve formation |
| HAS2 | Extracellular matrix component in cushions | Knockout affects cushion expansion |
| COL1A1 | Major extracellular matrix protein in valve leaflets | Mutations affect valve biomechanics |
| ELN | Elastin in valve tissue | Knockout alters valve structure |
| MMP2 | Matrix metalloproteinase in valve remodeling | Inhibition alters leaflet remodeling |
| TIMP1 | Regulates MMP activity in valve matrix | Overexpression affects valve development |
| SNAI1 | Induces EndoMT in endocardial cells | Knockdown blocks cushion formation |
| TWIST1 | Promotes mesenchymal phenotype in cushions | Knockout impairs valve development |
| PECAM1 | Endothelial marker in valve endocardium | Used for lineage tracing |
How Is atrioventricular valve development Regulated?
Atrioventricular valve development is regulated by a combination of transcriptional, signaling, and biomechanical inputs. TGF-beta and BMP signaling pathways control endothelial-to-mesenchymal transition and cushion formation. Notch signaling regulates cell fate decisions and leaflet stratification. Epicardial-derived signals, including WT1 and TBX18, modulate valve interstitial cell populations and matrix homeostasis. Biomechanical forces from blood flow and cardiac contraction are transduced into biochemical signals that regulate gene expression and tissue remodeling during valvulogenesis. Disruption of these regulatory networks can lead to congenital valve defects or acquired valve disease.
atrioventricular valve development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GATA4 | Atrioventricular septal defect | Knockout mouse, patient iPSC-derived cardiomyocytes |
| NKX2-5 | Congenital heart disease with AV valve abnormalities | Knock-in mouse, CRISPR point mutation |
| NOTCH1 | Valve disease and calcification | Conditional knockout, overexpression |
| WT1 | Myxomatous valve disease | Epicardial lineage tracing, knockout |
| TBX18 | AV valve maturation defects | Knockout and overexpression models |
Atrioventricular septal defects
Atrioventricular septal defects (AVSD) are congenital heart malformations that arise from abnormal development of the endocardial cushions and AV valves. Patients with AVSD often have a common atrioventricular valve and require surgical correction. After correction, some patients develop left atrioventricular valve regurgitation, which is a significant clinical complication. Studies of AV valve development provide insight into the molecular basis of AVSD and potential therapeutic targets.
Myxomatous valve disease
Myxomatous valve disease is characterized by thickening and degeneration of AV valve leaflets, leading to regurgitation. The epicardium plays a role in the development of AV valves, and its dysfunction is relevant to the pathogenesis of myxomatous valve disease. Research on epicardial contributions to valve development may identify new targets for preventing or treating this condition.
Valve regurgitation after transcatheter aortic valve replacement
Patients undergoing transcatheter aortic valve replacement (TAVR) can develop atrioventricular conduction disturbances and AV valve regurgitation. While these complications are primarily related to the procedure, understanding AV valve development and anatomy is important for device design and patient management. Real-world analyses have documented the incidence and predictors of these complications.
From atrioventricular valve development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate endothelial-to-mesenchymal transition in AV cushions? | Knockout of gene X in endocardial cells |
| Does a point mutation in gene Y cause AV valve malformation? | CRISPR point-mutation knock-in mouse |
| What is the role of epicardial cells in AV valve development? | Epicardial lineage tracing and conditional knockout |
| How does overexpression of gene Z affect valve leaflet remodeling? | Transgenic overexpression model |
| Can tagged knock-in of gene W reveal its localization during valve development? | CRISPR knock-in of fluorescent tag |
| Does biomechanical signaling through gene V affect valvulogenesis? | In vitro flow chamber with CRISPR-edited cells |
How to Study the atrioventricular valve development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lineage tracing | Cell fate and contribution to valve structures | Endocardial and epicardial origins |
| Single-cell RNA-seq | Gene expression heterogeneity in valve cells | Identifying novel regulators |
| Flow chamber assays | Shear stress effects on valve cells | Biomechanical signaling |
| CRISPR knockout | Loss-of-function effects on valve development | Gene function studies |
| CRISPR knock-in | Tagged protein localization and point mutations | In vivo imaging and disease modeling |
| Overexpression models | Gain-of-function effects on valvulogenesis | Testing gene dosage |
| Histology and immunostaining | Tissue morphology and protein expression | Valve leaflet structure |
| Echocardiography | Valve function and regurgitation in vivo | Clinical and animal studies |
Lineage tracing and imaging
Lineage tracing using Cre-lox systems and fluorescent reporters allows researchers to follow the fate of endocardial and epicardial cells during AV valve development. Confocal and light-sheet microscopy provide high-resolution images of valve morphogenesis in animal models.
Transcriptomics and single-cell RNA sequencing
RNA sequencing and single-cell RNA sequencing can identify gene expression programs in endocardial cushions, valve interstitial cells, and epicardial-derived cells during AV valve development. These methods reveal candidate regulators and cell heterogeneity in the developing valve.
Biomechanical assays
In vitro flow chambers and mechanical testing systems are used to study how shear stress and strain affect valve cell behavior and gene expression. These assays help link biomechanical cues to molecular pathways in valvulogenesis.
CRISPR-based functional genomics
CRISPR knockout, knock-in, and overexpression models enable systematic testing of gene function in AV valve development. Pooled CRISPR screens can identify novel regulators of endothelial-to-mesenchymal transition and valve remodeling.
How CRISPR Can Be Used to Study GO:0003171 atrioventricular valve development
Knockout
CRISPR knockout of candidate genes in endocardial or epicardial cells can reveal their requirement for AV valve development. For example, knocking out TGFB2 or BMP2 in mouse models disrupts endothelial-to-mesenchymal transition and cushion formation. Knockout models are essential for establishing causality in valve morphogenesis.
Point Mutation
CRISPR point mutation can model human variants associated with AV valve defects. Introducing specific mutations in genes such as GATA4 or NKX2-5 allows researchers to study their effects on valve development and disease. These models help distinguish pathogenic variants from benign polymorphisms.
Knock-in
Knock-in of fluorescent tags or reporter genes enables visualization of protein localization and cell lineage during AV valve development. Tagged knock-in models can also be used to isolate specific cell populations for transcriptomic analysis.
Overexpression
CRISPR-mediated overexpression or transgenic models can test the effects of increased gene dosage on valve development. Overexpression of VEGFA or other signaling molecules can alter cushion growth and valve remodeling. These models complement knockout studies to define optimal gene expression levels.
How EDITGENE Supports atrioventricular valve development Research
Researchers studying atrioventricular valve development-related genes often need to determine whether a candidate gene is causally involved in valve morphogenesis or disease. EDITGENE provides CRISPR-based cell models and screening services to accelerate functional validation of genes implicated in GO:0003171.
Contact EDITGENE today to design your custom CRISPR model for atrioventricular valve development research.
Frequently Asked Questions About atrioventricular valve development
What is atrioventricular valve development?
Atrioventricular valve development (GO:0003171) is the biological process by which the atrioventricular valves progress from formation to mature structure, ensuring unidirectional blood flow.
What genes are involved in atrioventricular valve development?
Genes such as TGFB2, BMP2, NOTCH1, GATA4, NKX2-5, WT1, and TBX18 are implicated in AV valve development.
What are the key stages of AV valve development?
Key stages include endocardial cushion formation, endothelial-to-mesenchymal transition, leaflet remodeling, tension apparatus formation, and maturation.
How does the epicardium contribute to AV valve development?
The epicardium provides cells and signals that contribute to valve interstitial cell populations and are important for preventing myxomatous valve disease.
What diseases are linked to defective AV valve development?
Defective AV valve development is linked to atrioventricular septal defects, valve regurgitation, and myxomatous valve disease.
What animal models are used to study AV valve development?
Mouse models with knockout, knock-in, and lineage tracing are commonly used, along with chick and zebrafish embryos.
How can CRISPR be used to study AV valve development?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional testing of genes in valve morphogenesis.
What is the role of biomechanics in AV valve development?
Biomechanical cues from blood flow and cardiac contraction direct valvulogenesis and regulate gene expression in valve cells.
What is the tension apparatus of the AV valve?
The tension apparatus includes chordae tendineae and papillary muscles that anchor valve leaflets and ensure proper coaptation.
Why is AV valve development important for congenital heart disease?
Disruptions in AV valve development cause congenital heart defects such as atrioventricular septal defects, which require surgical intervention.
Conclusion
Atrioventricular valve development (GO:0003171) is a complex biological process that integrates genetic, cellular, and biomechanical signals to form functional mitral and tricuspid valves. Defects in this process lead to congenital heart disease and valve regurgitation, making it a critical area of research. Advances in CRISPR-based models and imaging technologies are accelerating the discovery of genes and mechanisms underlying AV valve development. Understanding GO:0003171 will inform new strategies for diagnosing and treating valve disease.
References
- 1. de Vlaming A et al.. 2012. Atrioventricular valve development: new perspectives on an old theme.. Differentiation 84(1):103-16 PMID: 22579502
- 2. Wolters R et al.. 2021. Role of the Epicardium in the Development of the Atrioventricular Valves and Its Relevance to the Pathogenesis of Myxomatous Valve Disease.. J Cardiovasc Dev Dis 8(5) PMID: 34066253
- 3. Castro-Mejía AF et al.. 2022. Development of atrioventricular and intraventricular conduction disturbances in patients undergoing transcatheter aortic valve replacement with new generation self-expanding valves: A real world multicenter analysis.. Int J Cardiol 362:128-136 PMID: 35550389
- 4. Anderson RH et al.. 1996. The anatomy of the heart revisited.. Anat Rec 246(1):1-7 PMID: 8876818
- 5. Oosthoek PW et al.. 1998. Development of the atrioventricular valve tension apparatus in the human heart.. Anat Embryol (Berl) 198(4):317-29 PMID: 9764545
- 6. Löw K et al.. 2026. Development of atrioventricular valve regurgitation following transcatheter aortic valve replacement for severe aortic stenosis.. Clin Res Cardiol PMID: 42573757
- 7. Ahuja N et al.. 2020. Biomechanical Cues Direct Valvulogenesis.. J Cardiovasc Dev Dis 7(2) PMID: 32438610
- 8. Ten Harkel AD et al.. 2005. Development of left atrioventricular valve regurgitation after correction of atrioventricular septal defect.. Ann Thorac Surg 79(2):607-12 PMID: 15680844
